Thinking of joining a study?

Register your interest

Become a volunteer?

NCT05829824 | RECRUITING | Cancer

Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach
Sponsor:

University of California, San Francisco

Brief Summary:

This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.

Condition or disease

Cancer

Tobacco Dependence

Tobacco Use Cessation

Intervention/treatment

CareConnect

AutoReach

Biospecimen samples

Phase

NA

Detailed Description:

PRIMARY OBJECTIVE: I. To evaluate CareConnect's efficacy on referring patients to tobacco cessation resources. SECONDARY OBJECTIVE: I. To evaluate patients' acceptance of referrals. II. To evaluate the acceptability of CareConnect. EXPLORATORY OBJECTIVES: I. In-depth semi-structured qualitative interviews of 20 selectively chosen participants who completed the 3-month follow-up survey or finished the automated CareConnect or Auto-Reach call but may have refused to complete the 3-month follow-up survey (10 from each group). II. Smoking cessation with verification. OUTLINE: Eligible participants, identified through the Cancer Center Tobacco Registry will be randomized to either the Intervention or Control arm on a 1:1 ratio. Participants who complete the first call of CareConnect or AutoReach will be considered enrolled. Participants will complete a baseline assessment, a 3-month assessment, and have option to provide a saliva sample. For those who are selected to participate in an in-depth interview, this will take place within 1 month after the 3-month assessment. Data from the participants medical record may be accessed at 6 months post follow-up.

Study Type : INTERVENTIONAL
Estimated Enrollment : 400 participants
Masking : NONE
Primary Purpose : HEALTH_SERVICES_RESEARCH
Official Title : Connect Cancer Patients to Tobacco Cessation Care by Automated Interactive Outreach
Actual Study Start Date : 2023-11-27
Estimated Primary Completion Date : 2025-06-30
Estimated Study Completion Date : 2025-06-30

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • 1. Age 18 years and older.
  • 2. Able to understand study procedures and to comply with them for the entire length of the study.
  • 3. Ability of individual or legal guardian/representative to understand a written informed consent document, and the willingness to sign it.
  • 4. English, Spanish, Cantonese, or Mandarin speaking.
  • 5. Self-reported current use of tobacco, including e-cigarette on EHR.
  • 6. Has a diagnosis of cancer.
  • 7. Has been seen by a prescribing provider within a UCSF Cancer Center-affiliated clinical department within the past 3 months.
Exclusion Criteria
  • 1. Contraindication to any study-related procedure or assessment.
  • 2. No valid contact telephone number.
  • 3. Currently hospitalized or having been discharged from inpatient setting within the past month (according to EHR).
Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach

Location Details

NCT05829824

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, California

University of California, San Francisco

San Francisco, California, United States, 94143